Ethical Dilemmas in Anaesthesiology in the Netherlands; a Qualitative Interview Study. (AnaesthEthics)

This study will describe which ethical dilemmas are experienced by anesthesiologist in the Dutch Healthcare system and what the current solving strategies are for these issues. Semi- structured interviews will be conducted with anaesthesiologists employed in different hospitals in the Netherlands..

Study Overview

Detailed Description

Ethical considerations are part of a doctors daily practice. The development of anaesthesiologists as ' perioperative' doctors is increasingly giving anaesthesiologists a treatment function. As the third largest medical specialty, they are also involved in ethical dilemmas. Examples of common themes in the literature include:' informed consent' and professionalism. Nevertheless, good research into ethical dilemmas in the field of anaesthesiology is lacking.

Study Type

Observational

Enrollment (Anticipated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Amsterdam, Netherlands, 1105 AZ
        • Recruiting
        • Academic Medical Centre
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

anaesthetist employed in the Netherlands working in a academic of non-academic hospital.

Description

Inclusion Criteria:

  • Participant is willing and able to give informed consent for participation in the study.
  • Employed as anaesthesiologist
  • Employed in an academic or non-academic hospital in the Netherlands

Exclusion Criteria:

  • Other medical specialists
  • language barrier

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Other

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
interviews (qualitative interview study)
Time Frame: 10 years (depends on working experience of the respondent)
Categories of ethical dilemmas experienced during work as assessed by interviews
10 years (depends on working experience of the respondent)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: M. W Hollmann, AIDS Malignancy Consortium

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 20, 2018

Primary Completion (Anticipated)

December 20, 2018

Study Completion (Anticipated)

January 20, 2019

Study Registration Dates

First Submitted

January 23, 2018

First Submitted That Met QC Criteria

January 29, 2018

First Posted (Actual)

February 5, 2018

Study Record Updates

Last Update Posted (Actual)

February 5, 2018

Last Update Submitted That Met QC Criteria

January 29, 2018

Last Verified

January 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • AE1-AMC

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

De identified individual participant data for all primary and secondary outcome measures will be made available

IPD Sharing Time Frame

within 6 months of study completion

IPD Sharing Access Criteria

data acces will be reviewed. requestors will be required to sign a data access agreement

IPD Sharing Supporting Information Type

  • Study Protocol
  • Statistical Analysis Plan (SAP)
  • Clinical Study Report (CSR)
  • Analytic Code

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ethical Dilemmas

Clinical Trials on no intervention

3
Subscribe